LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Apr 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-04-04

Reporting Person: May Larry Alan (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-04	Stock Options (right to buy)	$1.74	A	350000	Acquired	2021-04-03	Common Stock, par value $0.001 per share (350000)	Direct

Footnotes

F1: On April 4, 2011, Mr. May was granted a stock option to purchase 350,000 shares of Common Stock under the Company's 2009 Equity Compensation Plan (the "2009 Plan"). Options as to 175,000 shares vested on the date of the grant and options as to the remaining 175,000 shares will vest on April 4, 2012. The option is subject to all the terms and conditions of the 2009 Plan.